Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Genetically Modified T Cells Against Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification
- Status
- COMPLETED
- Phase
- NA
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Intermittent Fasting Accompanying Chemotherapy in Gynecological Cancers
- Status
- UNKNOWN
- Phase
- NA
Homologous Recombination Inquiry Through Ovarian Malignancy Investigations
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast
- Status
- COMPLETED
- Phase
- PHASE1
EDMONd - Elemental Diet in Bowel Obstruction
- Status
- UNKNOWN
- Phase
- NA
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
- Status
- UNKNOWN
- Phase
- NA
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
MAGE-A4ᶜ¹º³²T for Multi-Tumor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Long Term Survivors in Ovarian Cancer
- Status
- TERMINATED
- Phase
- N/A
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families
- Status
- COMPLETED
- Phase
- N/A